Table 2.

The participants’ lipid concentrations during baseline and vitamin C interventions.

	Triglycerides (mmol/L)		Cholesterol (mmol/L)		Total Lipids (mmol/L)		α-Tocopherol (µmol/L)		α-T/Cholesterol (mmol/mol)		α-T/Lipids (mmol/mol)
#	Baseline	Vitamin C	Baseline	Vitamin C	Baseline	Vitamin C	Baseline	Vitamin C	Baseline	Vitamin C	Baseline	Vitamin C
1	0.48	0.42	2.61	2.39	3.09	2.82	6.99	5.03	2.66	2.11	2.25	1.80
2	0.41	0.41	3.62	3.30	4.03	3.72	17.91	16.17	4.96	4.89	4.45	4.35
3	0.93	0.87	3.86	3.40	4.79	4.27	20.73	19.08	5.39	5.61	4.34	4.47
4	0.32	0.34	4.34	3.78	4.65	4.13	13.41	15.16	3.09	4.03	2.88	3.69
5	0.28	0.27	2.21	2.15	2.49	2.42	7.18	9.51	3.26	4.42	2.89	3.93
6	0.35	0.28	2.50	2.68	2.86	2.95	8.61	7.72	3.47	2.89	3.05	2.62

Cholesterol and triglyceride concentrations did not differ significantly between the two trials; however, their sum shown as total lipids (3.65 ± 0.97 vs. 3.38 ± 0.76) was slightly lower during the vitamin C (Vit C) intervention (p = 0.0467). Plasma unlabeled α-Tocopherol (α-T), α-T/cholesterol and α-T/lipids were not significantly different between the two interventions. Lipid levels were not used to modify vitamin E pharmacokinetics.